Substitution of carbonyl group of ellagic acid with silanediol group for better inhibition of VEGFR-2 Kinase enzyme What is cancer? The major cause of death worldwide is cancer. Surgery, chemotherapeutic agents and radiation which are cancer therapy have not been much efficient in the reduction of cancer occurrence and raising …
Read More »Withaferin A (WIT) interaction with β–Tubulin
Withaferin A (WIT) interaction with β–Tubulin Withaferin A (WIT) Withaferin A (WIT) is an important natural compound extracted from the Indian medicinal plant Withania somnifera. This plant has been used for over 3000 years in Unani Indian medical system. Also, its extracted medicinal compound has been in ayurvedic medicine and …
Read More »Design of novel tazarotene derivatives
Design of novel tazarotene derivatives as potential antipsoriatic drugs What is Psoriasis? Psoriasis is a prevalent chronic inflammatory skin condition afflicting about 2-4% of patients all over the world. Psoriasis is mostly characterized by the skin covered with red, well-defined, hardened plaques with silver and micaceous scale. Complications associated …
Read More »Molecular structure and stability of 99mTc-MDP
The molecular structure and the stability parameters of 99mTc-MDP Medronate, commonly known as methylene diphosphonate or MDP, is the smallest bisphosphonates, recognized as a family of drugs used in treatment of various bone diseases. Bisphosphonates are the structural analogs of native pyrophosphate with a P-C-P backbone instead of P-O-P. The …
Read More »Dr. Mehdi Nabati
Curriculum vitae *************************************** Mehdi Nabati Ph.D. of Organic Chemistry Date of Birth: 22/04/1988 Place of Birth: Maragheh, East Azarbaijan, Iran Marital Status: Single Mobile Number: +989011828140 E-mail: mnabati@ymail.com *************************************** EDUCATION AND RESEARCH Azarbaijan Shahid Madani University, Tabriz, Iran . Ph.D., Organic Chemistry, with Dr. Mehrdad Mahkam, Sept. 2012 – ۲۰۱۵ …
Read More »